agilon health, inc. Q3 2025 Earnings Recap

Agilon Health's Q3 2025 showed revenue of $1.44 billion, but continued challenges resulted in a negative medical margin of $57 million and adjusted EBITDA of negative $91 million. The company is focused on improving performance through enhanced data analytics and revisiting its guidance for 2025.

Key Takeaways

• Revenue for Q3 2025 reached $1.44 billion, impacted by lower-than-expected risk scores and high costs from exited markets.
• The company has reinstated 2025 guidance, projecting a revenue midpoint of $5.82 billion and an adjusted EBITDA of negative $258 million.
• Enhanced data pipeline now supports 80% of members with timely analytics, positioning agilon for improved forecasting and operational efficiencies.
• Approximately 75% of agilon's members are expected to be in plans rated 4 stars or higher for 2026, outperforming the broader Medicare Advantage average.
• The company is proactively negotiating payer contracts for 2026, focusing on improved terms and profitability, even at the potential expense of reduced membership.